Synonyms CCNK, CPR4, cyclin K + [1] |
Introduction Regulatory subunit of cyclin-dependent kinases that mediates activation of target kinases. Plays a role in transcriptional regulation via its role in regulating the phosphorylation of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A). |
Target |
Mechanism Cyclin-K degraders [+2] |
Active Org. Carrick Therapeutics Ltd.Startup [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism Cyclin-K degraders |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism Cyclin-K degraders [+2] |
Active Org. Carrick Therapeutics Ltd.Startup |
Originator Org. Carrick Therapeutics Ltd.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date16 Aug 2024 |
Sponsor / Collaborator Carrick Therapeutics Ltd.Startup |